Clinical Trial Update: Auto Transplant High Dose Melphalan vs High Dose Melphalan+Bortezomib in Pts With Multiple Myeloma Age 65 Years or Older [Phase 2]

View source ↗

Summary

Phase 2 trial comparing autologous stem cell transplant with high-dose melphalan versus high-dose melphalan plus bortezomib in patients aged 65 and older with m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Alkeran (melphalan)
• Velcade (bortezomib)

Snippet

Sponsor: Hackensack Meridian Health | Conditions: Multiple Myeloma | Phase 2 | Status: TERMINATED | Results posted: 2023-11-28